Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 17351-17400 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03610451
Floatation-REST and Anorexia Nervosa
NAActive, not recruiting
68 participants
Started: Mar 16, 2018 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT03314636
Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment.
PHASE2Active, not recruiting
53 participants
Started: Mar 16, 2018 · Completed: Nov 1, 2026
1 condition2 sponsors4 locations
NCT03220022
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
PHASE1Active, not recruiting
46 participants
Started: Mar 16, 2018 · Completed: Jul 16, 2026
4 conditions1 sponsor19 locations
NCT03459846
A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
PHASE2Active, not recruiting
154 participants
Started: Mar 16, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor44 locations
NCT03758326
A New Measure of Body Image in Eating Disorders
NAActive, not recruiting
135 participants
Started: Mar 16, 2018 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT03341936
Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN
PHASE2Active, not recruiting
29 participants
Started: Mar 15, 2018 · Completed: Jul 6, 2026
1 condition2 sponsors1 location
NCT03383094
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
PHASE2Active, not recruiting
126 participants
Started: Mar 15, 2018 · Completed: Dec 31, 2027
15 conditions2 sponsors6 locations
NCT03510858
Randomized Controlled Trial on Colorectal Cancer Screening Among Quality Circles of Primary Care Physicians
NAActive, not recruiting
44 participants
Started: Mar 14, 2018 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT03239808
Incremental Haemodialysis in Incident Patients
NAActive, not recruiting
152 participants
Started: Mar 14, 2018 · Completed: Jun 30, 2025
1 condition21 sponsors3 locations
NCT03414970
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
PHASE3Active, not recruiting
897 participants
Started: Mar 12, 2018 · Completed: Aug 31, 2035
9 conditions3 sponsors859 locations
NCT03282695
Ozone Therapy in Patients on Waiting List for Surgery Due to Disc Herniation: Prospective, Post-authorization Study
N/AActive, not recruiting
70 participants
Started: Mar 9, 2018 · Completed: Mar 31, 2026
1 condition5 sponsors1 location
NCT03232268
HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies
PHASE1Active, not recruiting
25 participants
Started: Mar 9, 2018 · Completed: Mar 9, 2027
2 conditions1 sponsor1 location
NCT03576742
Severe Immune Cytopenia Registry Www.Sic-reg.Org
N/AActive, not recruiting
80 participants
Started: Mar 9, 2018 · Completed: Dec 31, 2024
4 conditions1 sponsor1 location
NCT03415035
Study Venetoclax Effectiveness and Real-Life Treatment Management in Participants With Chronic Lymphocytic Leukemia
N/AActive, not recruiting
269 participants
Started: Mar 9, 2018 · Completed: Jun 30, 2026
1 condition1 sponsor60 locations
NCT03422822
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
PHASE3Active, not recruiting
3,166 participants
Started: Mar 8, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor539 locations
NCT03448835
Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)
PHASE2Active, not recruiting
20 participants
Started: Mar 7, 2018 · Completed: Oct 31, 2026
2 conditions2 sponsors2 locations
NCT03330847
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
PHASE2Active, not recruiting
273 participants
Started: Mar 7, 2018 · Completed: Dec 10, 2025
1 condition1 sponsor141 locations
NCT03465618
A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
PHASE1Active, not recruiting
17 participants
Started: Mar 7, 2018 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT03441958
ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Mar 7, 2018 · Completed: Oct 17, 2025
1 condition3 sponsors1 location
NCT03667651
The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants
PHASE3Active, not recruiting
760 participants
Started: Mar 6, 2018 · Completed: May 31, 2027
3 conditions1 sponsor4 locations
NCT06098326
CyFluATG in Lower Risk MDS
PHASE2Active, not recruiting
30 participants
Started: Mar 6, 2018 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03360721
Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer
PHASE2Active, not recruiting
7 participants
Started: Mar 6, 2018 · Completed: Apr 30, 2027
5 conditions2 sponsors1 location
NCT03762096
Short Interval Resveratrol Trial in Cardiovascular Surgery
NAActive, not recruiting
40 participants
Started: Mar 6, 2018 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT03395587
Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma
PHASE2Active, not recruiting
136 participants
Started: Mar 6, 2018 · Completed: May 31, 2027
1 condition2 sponsors6 locations
NCT03420404
Clinical Trial of TCM Collaborative Care Model in Axial Spondyloarthritis
NAActive, not recruiting
140 participants
Started: Mar 5, 2018 · Completed: Dec 31, 2025
1 condition5 sponsors1 location
NCT03438708
Prior Axitinib as a Determinant of Outcome of Renal Surgery
PHASE2Active, not recruiting
22 participants
Started: Mar 5, 2018 · Completed: Mar 4, 2026
1 condition2 sponsors2 locations
NCT03431090
Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Mar 2, 2018 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT03431350
A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer
PHASE2Active, not recruiting
136 participants
Started: Mar 2, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor50 locations
NCT02991677
Exercise Effect on Chemotherapy-Induced Neuropathic Pain
NAActive, not recruiting
60 participants
Started: Mar 1, 2018 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT03436290
Surgery for Cancer With Option of Palliative Care Expert
NAActive, not recruiting
236 participants
Started: Mar 1, 2018 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT03552627
Perioperative UtiLisation of SupplEmental Oxygen
PHASE4Active, not recruiting
28 participants
Started: Mar 1, 2018 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03490240
Project BIPAMS: Behavioral Intervention for Physical Activity in Multiple Sclerosis
NAActive, not recruiting
280 participants
Started: Mar 1, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03828513
Can the Effects of High Flow Nasal Cannula Oxygenation on Postoperative Atelectasis be Evaluated With Lung Ultrasound
NAActive, not recruiting
100 participants
Started: Mar 1, 2018 · Completed: Mar 30, 2025
3 conditions1 sponsor1 location
NCT03477513
Personalized Radiation Therapy for GBM
NAActive, not recruiting
20 participants
Started: Mar 1, 2018 · Completed: Jul 30, 2026
1 condition1 sponsor1 location
NCT04931498
Molecular Investigation of GENetic Factors in Cardiovascular and Immune-related Traits and Diseases Using a BIOresource of Healthy Volunteers (GENBIO)
N/AActive, not recruiting
100 participants
Started: Mar 1, 2018 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT03287024
BeGrow Study to Treat Pulmonary Artery (PA) Stenosis in Newborns and Infants
NAActive, not recruiting
18 participants
Started: Mar 1, 2018 · Completed: May 31, 2027
1 condition1 sponsor3 locations
NCT03389802
Phase I Study of APX005M in Pediatric Central Nervous System Tumors
PHASE1Active, not recruiting
32 participants
Started: Mar 1, 2018 · Completed: Nov 1, 2025
6 conditions7 sponsors11 locations
NCT04227665
Identifying Biological Markers for Altitude Exposure and Use of Recombinant Human Erythropoietin (rHuEPO)
NAActive, not recruiting
40 participants
Started: Mar 1, 2018 · Completed: May 30, 2025
1 condition5 sponsors1 location
NCT03435679
One-stage Versus Two-stage Revision of the Infected Knee Arthroplasty
NAActive, not recruiting
97 participants
Started: Mar 1, 2018 · Completed: Nov 18, 2026
1 condition3 sponsors9 locations
NCT05365087
Transoral Fundoplication Prior to Sleeve Gastrectomy Versus RNY Gastric Bypass on GERD Symptoms in Bariatric Patients
N/AActive, not recruiting
180 participants
Started: Mar 1, 2018 · Completed: Dec 31, 2032
1 condition1 sponsor1 location
NCT03223103
Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
PHASE1Active, not recruiting
13 participants
Started: Mar 1, 2018 · Completed: May 12, 2029
1 condition2 sponsors1 location
NCT03413254
Second and Third Look Laparoscopy in pT4 Colon Cancer Patients for Early Detection of Peritoneal Metastases
PHASE3Active, not recruiting
389 participants
Started: Mar 1, 2018 · Completed: Oct 1, 2028
2 conditions1 sponsor10 locations
NCT03888820
Biofreeze® vs. a Placebo on Chronic Low Back Pain Walking Gait Characteristics and Pain
PHASE4Active, not recruiting
20 participants
Started: Mar 1, 2018 · Completed: Apr 30, 2019
1 condition1 sponsor1 location
NCT05112198
Digital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer
NAActive, not recruiting
41 participants
Started: Mar 1, 2018 · Completed: Sep 30, 2025
1 condition2 sponsors2 locations
NCT06385483
Testing Afatinib as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH - Subprotocol A)
PHASE2Active, not recruiting
19 participants
Started: Feb 28, 2018 · Completed: Dec 31, 2025
5 conditions1 sponsor1 location
NCT03429803
DAY101 In Gliomas and Other Tumors
PHASE1Active, not recruiting
44 participants
Started: Feb 27, 2018 · Completed: Dec 31, 2025
1 condition6 sponsors15 locations
NCT03377569
Subcortical Oscillations in Human Sleep Dysregulation
N/AActive, not recruiting
15 participants
Started: Feb 27, 2018 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT03554174
Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
PHASE1Active, not recruiting
18 participants
Started: Feb 27, 2018 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT03386617
AKY15-HK-301_NEPA Study
PHASE2Active, not recruiting
55 participants
Started: Feb 27, 2018 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT03380962
Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Feb 27, 2018 · Completed: Aug 30, 2025
7 conditions1 sponsor1 location